Anti-Mullerian Hormone Levels Before and After an Open Myomectomy
Anti-Mullerian Hormone Levels Variations Following an Open Myomectomy
Sponsor: Clinique Ovo
Terminated
It has been put on hold for the moment due to logistic problems
Other terminated trials from Clinique Ovo
- PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries · Jan 2025
- Repeated Embryo Implantation Failure · Phase PHASE3 · Dec 2017
- Infertility · Jan 2017
- Infertility · Phase NA · Aug 2016
- Pregnancy · Jun 2015
More terminations from Clinique Ovo
Listed as NCT01723085, this observational or N/A phase trial focuses on Anti-Mullerian Hormone and remains terminated or withdrawn. Sponsored by Clinique Ovo, it has been updated 12 times since 2012, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Dec 2021 — Jul 2024 [monthly]
Terminated
-
Oct 2021 — Dec 2021 [monthly]
Terminated
-
Jan 2021 — Oct 2021 [monthly]
Terminated
▶ Show 7 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Terminated
-
Aug 2018 — Nov 2020 [monthly]
Terminated
Status: Suspended → Terminated
-
Jun 2018 — Aug 2018 [monthly]
Suspended
-
May 2018 — Jun 2018 [monthly]
Suspended
-
Apr 2018 — May 2018 [monthly]
Suspended
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Suspended NA
-
Jan 2017 — Aug 2017 [monthly]
Suspended NA
First recorded
Mar 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Clinique Ovo
For direct contact, visit the study record on ClinicalTrials.gov .